Additionally, this research group indicated that miR-18a potentially increases radiosensitivity by targeting ataxia telangiectasia mutated (ATM) and hypoxia-inducible factor 1 alpha (HIF-1α) in lung cancer cells and CD133+ stem cells. Here, ATM is linked to lung cancer.